Read + Share
Amedeo Smart
Independent Medical Education
Dawwas GK, Cuker A, Barnes GD, Lewis JD, et al. Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study. Ann Intern Med 2022 Oct 18. doi: 10.7326/M22-0318.PMID: 36252244
Email
LinkedIn
Facebook
Twitter
Privacy Policy